Vaxcyte Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Investment Phase VTEX Q1 2026 Earnings EPS Misses Estimates Stock Declines XPEL Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Disclosure TAYD Q1 2026 Earnings EPS Slightly Above Estimates Amid Strong Operational Performance RDW Q1 2026 Earnings WiderThanExpected Loss but Stock Surges on Strategic Momentum UG Q2 2025 Earnings EPS of 014 Reported Stock Climbs as Profitability Holds Steady